14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
OFIX vs KTWO: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 20, 2026, Orthofix Medical Inc. (OFIX) is the stronger overall head-to-head candidate over KTWO (KTWO) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). OFIX carries a Unified Composite Score of 47.8/100 (HOLD) at $6.07 (N/M Forward P/E, -2.1% operating margin), whereas KTWO carries 55.8/100 (HOLD) at $10.12 (N/M Forward P/E, N/A operating margin).
Composite vs. Pillar Nuance: While KTWO currently prints a higher short-term Unified Composite Score (55.8/100 HOLD vs. OFIX 47.8/100 HOLD), OFIX captures the overall institutional head-to-head verdict (5–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-2.1% vs. N/A operating margin) and revenue trajectory (+1.1% vs. N/A YoY).
Technical & Structure Timing Caution: OFIX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.7); meanwhile KTWO trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 57.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OFIX vs KTWO. Trailing 12-month operating profitability (OFIX -2.1% vs KTWO N/A) and valuation multiples (OFIX N/M vs KTWO N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ OFIX vs KTWO Key Questions & Quantitative Answers
As of Nov 20, 2026, Orthofix Medical Inc. (OFIX) is the stronger overall head-to-head candidate over KTWO (KTWO) in the Tradestie Institutional Equity Comparison Engine, winning 5–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). OFIX carries a Unified Composite Score of 47.8/100 (HOLD) at $6.07 (N/M Forward P/E, -2.1% operating margin), whereas KTWO carries 55.8/100 (HOLD) at $10.12 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While KTWO currently prints a higher short-term Unified Composite Score (55.8/100 HOLD vs. OFIX 47.8/100 HOLD), OFIX captures the overall institutional head-to-head verdict (5–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (-2.1% vs. N/A operating margin) and revenue trajectory (+1.1% vs. N/A YoY). Technical & Structure Timing Caution: OFIX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 25.7); meanwhile KTWO trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 57.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
OFIX leads the Growth & Scale pillar: OFIX posts +1.1% YoY revenue growth and +0.0% YoY earnings growth on $835M TTM revenue (70.8% gross margin, -2.1% operating margin), compared with KTWO at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, OFIX generates $835M in USD-normalized revenue versus N/A for KTWO. In operating R&D and SG&A reinvestment, OFIX deploys 72.9% of Rev ($609M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for KTWO.
OFIX screens cheaper on headline valuation multiples. OFIX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.3x EV/Revenue (4.9% EBITDA margin), whereas KTWO trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against OFIX (-10.3% ROE) versus KTWO (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, OFIX carries 40.1% implied volatility (3rd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.05β · 83% Vol realized risk). By comparison, KTWO carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.02β · 4% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.